Trial intelligence / Profile preview

Pentoxifylline in Steroid-naive Duchenne Muscular Dystrophy

NCT00102453Phase 2Completed

Sponsor
Cooperative International Neuromuscular Research Group
Start
Mar 2002
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pentoxifylline in Duchenne muscular dystrophy (DMD), sponsored by Cooperative International Neuromuscular Research Group. Started Mar 2002; status: completed.

02

Drugs

pentoxifylline
03

Conditions

Duchenne muscular dystrophy (DMD)

Beyond the preview

Go deeper on NCT00102453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00102453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call